USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NANOSCALE MATERIALS, INC.
Address:
1310 RESEARCH PARK DR
MANHATTAN, KS 66502-
Phone:
N/A
URL:
N/A
EIN:
481172548
DUNS:
946856804
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,000.00 1
SBIR Phase II $1,000,000.00 1
STTR Phase I $100,000.00 1

Award List:

FUNCTIONALIZED BIMAGNETIC CORE/SHELL FE/FE3O4 STEALTH NANOPART

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$1,000,000.00
Agency:
HHS
Principal Investigator:
Franklin Kroh
Abstract:
Early diagnosis and treatment of cancer greatly improve the likelihood of long-term survival and health. In Phase I, NanoScale Corporation and its partners at Kansas State University developed functionalized cancer-seeking "stealth" Fe/Fe3O4 core/shell nanoparticles, and demonstrated their… More

Protective Apparel Fabrics (PAF) with Distinctly Area-Specific Waterproof and Breathable Properties

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$100,000.00
Agency:
DOE
Principal Investigator:
Research Institution:
Clemson University
RI Contact:
Christine Cole
Abstract:
The end of the Cold War left the DOE with a surplus of nuclear facilities, which must now be deactivated and decommissioned (D&D). Appropriate protective apparel capable of shielding workers against a variety of hazardous materials such as airborne plutonium, mercury, organic solvents, asbestos, and… More

DEVELOPMENT OF A RAPID IN VITRO SCREENING ASSAY FOR DETECTION OF CANCER BIOMARKERS IN URINE AND BLOOD.

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$200,000.00
Agency:
HHS
Principal Investigator:
Frank Kroh – 785-537-0179
Abstract:
The goal of the project is to develop a rapid in vitro screening assay for detection of cancer biomarkers in urine and blood. The aim is testing and optimization of nanoparticle sensors, based on cyanine dyes that are chemically linked to Fe/Fe3O4 nanoparticles via protease-selective consensus… More